Clinical features and hormonal characteristics in a case of ovarian arrhenoblastoma

[1]  M. Maeyama,et al.  Endocrine studies on ovarian androblastomas (Sertoli-Leydig tumors) , 1984, Journal of endocrinological investigation.

[2]  T. Mckenna,et al.  Amenorrhea with cryptic hyperandrogenemia. , 1983, The Journal of clinical endocrinology and metabolism.

[3]  R. Lobo,et al.  Effect of androgen excess on inappropriate gonadotropin secretion as found in the polycystic ovary syndrome. , 1982, American journal of obstetrics and gynecology.

[4]  R. Kopher,et al.  The Clitoral Index: A Bioassay of Androgenic Stimulation , 1979, Obstetrics and gynecology.

[5]  P. A. Lee,et al.  An attenuated form of congenital virilizing adrenal hyperplasia. , 1979, The Journal of clinical endocrinology and metabolism.

[6]  J. C. Pita,et al.  Evidence that testosterone can suppress pituitary gonadotropin secretion independently of peripheral aromatization. , 1979, The Journal of clinical endocrinology and metabolism.

[7]  M. Soules,et al.  The Steroid Profile of a Virilizing Ovarian Tumor , 1978, Obstetrics and gynecology.

[8]  R. Demopoulos,et al.  Gonadotropin receptors in experimentally induced ovarian tumors in mice. , 1977, Cancer research.

[9]  F. Naftolin,et al.  Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. , 1976, The Journal of clinical investigation.

[10]  W. Wiser,et al.  A testosterone-secreting, gonadotropin-responsive pure thecoma and polycystic ovarian disease. , 1975, The Journal of clinical endocrinology and metabolism.

[11]  J. Louvet,et al.  Evidence for a Role of Androgens in Follicular Maturation , 1975 .

[12]  J. Tucci,et al.  Endocrine studies in an arrhenoblastoma responsive to dexamethasone, ACTH and human chorionic gonadotropin. , 1973, The American journal of medicine.